N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine N-(2,6-二氯苯基)-4,5-二氢-1H-咪唑-2-胺

CAS 4205-90-7 MFCD04205907

化学结构图

4205-90-7
SMILES: Clc1cccc(Cl)c1NC1=NCCN1

化学属性

Appearance 熔点130℃。可乐定盐酸盐,C9H9CI2N3·HCI,[4505-91-8],Clonidine hydrochloride,Catapres。白色结晶性粉末,熔点305℃。溶于水、乙醇,几乎不溶于氯仿、乙醚。无臭。
Mol. Weight230.09
Mol. FormulaC9H9Cl2N3
Melting Point141 - 144ºC
Boiling Point
Flash Point-

别名和识别编码

Chemical NameN-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine
Chemical Name TranslationN-(2,6-二氯苯基)-4,5-二氢-1H-咪唑-2-胺
CAS Number4205-90-7
Synonym Clonidine {LY} Clonidine {} {LY} Clonidine {} {} {LY} Clonidine {} {} {} {LY} Clonidine {} {} {} {} {LY} Clonidine {} {} {} {} {} {LY} Clonidine {} {} {} {} {} {} {LY} Clonidine {} {} {} {} {} {} {} {LY} Clonidine {} {} {} {} {} {} {} {} {LY} Clonidine {} {} {} {} {} {} {} {} {} {LY} Clonidine {} {} {} {} {} {} {} {} {} {} {LY} Clonidine {} {} {} {} {} {} {} {} {} {} {} {LY} Clonidine {} {} {} {} {} {} {} {} {} {} {} {} {LY} Clonidine {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} Clonidine {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} Clonidine {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} Clonidine {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} { {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} Clonidine {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} { {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} Clonidine {} {} {} {} {} {} {} {} {} {} {} {} {}
EC Number224-119-4
LabNetwork Molecule IDLN00326971
MDL NumberMFCD00055059
PubChem Substance ID2803
InChIInChI=1S/C9H9Cl2N3/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9/h1-3H,4-5H2,(H2,12,13,14)
Canonical SMILESClC1=C(NC2=NCCN2)C(Cl)=CC=C1
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

相关文献及参考

  • [1]. Alojado ME, et al. The effect of clonidine on the activity of neurons in the rat dorsal raphe nucleus in vitro. Anesth Analg. 1994 Aug;79(2):257-60.

安全信息

RTECSNJ2487000
TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 108 mg/kg
TOXIC EFFECTS :
   Behavioral - somnolence (general depressed activity)
   Behavioral - ataxia
   Skin and Appendages - hair
REFERENCE :
   IYKEDH Iyakuhin Kenkyu.  Study of Medical Supplies.  (Nippon Koteisho
   Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan)  V.1- 1970- 
   Volume(issue)/page/year: 18,366,1987

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 88400 ug/kg
TOXIC EFFECTS :
   Sense Organs and Special Senses (Eye) - chromodacryorrhea
   Behavioral - tremor
   Behavioral - ataxia
REFERENCE :
   KSRNAM Kiso to Rinsho.  Clinical Report.  (Yubunsha Co., Ltd., 1-5, Kanda
   Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan)  V.1-    1960-
   Volume(issue)/page/year: 26,4835,1992

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Administration onto the skin
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : >70 mg/kg
TOXIC EFFECTS :
   Sense Organs and Special Senses (Olfaction) - effect, not otherwise
   specified
   Sense Organs and Special Senses (Eye) - chromodacryorrhea
   Sense Organs and Special Senses (Eye) - effect, not otherwise specified
REFERENCE :
   OYYAA2 Oyo Yakuri.  Pharmacometrics.  (Oyo Yakuri

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Mammal - species unspecified
DOSE/DURATION           : 102 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   ARZNAD Arzneimittel-Forschung. Drug Research.  (Editio Cantor Verlag,
   Postfach 1255, W-7960 Aulendorf, Fed

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - rat
DOSE                    : 2080 ug/kg
SEX/DURATION            : female 8-20 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight
   gain)
REFERENCE :
   NRTXDN Neurotoxicology.  (Intox Press, Inc., POB 34075, Little Rock, AR
   72203)  V.1-    1979-  Volume(issue)/page/year: 9,559,1988

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - mouse
DOSE                    : 20 mg/kg
SEX/DURATION            : female 11 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
   e.g., stunted fetus)
REFERENCE :
   TJADAB Teratology, The International Journal of Abnormal Development. (Alan
   R. Liss, Inc., 41 E. 11th St., New York, NY 10003)  V.1-    1968-
   Volume(issue)/page/year: 32,19A,1985

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - mouse
DOSE                    : 10 mg/kg
SEX/DURATION            : female 11 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Specific Developmental Abnormalities - craniofacial
   (including nose and tongue)
REFERENCE :
   TJAD

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - rat
DOSE                    : 2100 mg/kg
SEX/DURATION            : female 1-21 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Effects on Newborn - other postnatal measures or effects
REFERENCE :
   NETEEC Neurotoxicology and Teratology.  (Pergamon Press Inc., Maxwell House,
   Fairview Park, Elmsford, NY 10523)  V.9-    1987- Volume(issue)/page/year:
   12,359,1990

Hazard statements
  • H301 Toxic if swallowed 吞食有毒
  • H310 Fatal in contact with skin 皮肤接触致命
  • H330 Fatal if inhaled 吸入致命
Precautionary statements
  • P260 Do not breathe dust/fume/gas/mist/vapours/spray. 不要吸入粉尘/烟/气体/烟雾/蒸汽/喷雾。
  • P262 Do not get in eyes, on skin, or on clothing. 不要接触眼睛,皮肤或衣服。
  • P264 Wash hands thoroughly after handling. 处理后要彻底洗净双手。
  • P270 Do not eat, drink or smoke when using this product. 使用本产品时不要吃东西,喝水或吸烟。
  • P271 Use only outdoors or in a well-ventilated area.? 只能在室外或通风良好的地方使用。
  • P280 Wear protective gloves/protective clothing/eye protection/face protection. 戴防护手套/防护服/眼睛的保护物/面部保护物。
  • P284 Wear respiratory protection.? 佩戴呼吸保护装置。
  • P301+P310
  • P301+P316
  • P302+P350
  • P302+P352
  • P304+P340
  • P310 Immediately call a POISON CENTER or doctor/physician. 立即呼救解毒中心或医生/医师。
  • P316
  • P320 Specific treatment is urgent (see … on this label). 紧急具体治疗(见本标签上的)。
  • P321 Specific treatment (see … on this label). 具体治疗(见本标签上的)。
  • P322 Specific measures (see …on this label). 具体治疗(见本标签上的)。
  • P330 Rinse mouth. 漱口
  • P361 Remove/Take off immediately all contaminated clothing. 立即去除/脱掉所有被污染的衣服。
  • P361+P364
  • P363 Wash contaminated clothing before reuse. 被污染的衣服洗净后方可重新使用。
  • P403+P233
  • P405 Store locked up. 上锁保管。
  • P501 Dispose of contents/container to..… 处理内容物/容器.....
Storage condition 2-8°C, protect from light {LY} 2-8°C, protect from light 4 4°C {} {LY} 2-8°C, protect from light {} {} {LY} 2-8°C, protect from light {} {} {} {LY} 2-8°C, protect from light {} {} {} {} {LY} 2-8°C, protect from light {} {} {} {} {} {LY} 2-8°C, protect from light {} {} {} {} {} {} {LY} 2-8°C, protect from light {} {} {} {} {} {} {} {LY} 2-8°C, protect from light {} {} {} {} {} {} {} {} {LY} 2-8°C, protect from light {} {} {} {} {} {} {} {} {} {LY} 2-8°C, protect from light {} {} {} {} {} {} {} {} {} {} {LY} 2-8°C, protect from light {} {} {} {} {} {} {} {} {} {} {} {LY} 2-8°C, protect from light {} {} {} {} {} {} {} {} {} {} {} {} {LY} 2-8°C, protect from light {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} 2-8°C, protect from light {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} 2-8°C, protect from light {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} 2-8°C, protect from light {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} 2-8°C, protect from lig

其他信息

  • 药理作用:盐酸可乐定为中枢性降压药,能激活血管运动中枢α2受体,引起外周交感神经抑制,导致血管扩张,使心输出量减少,心率减慢,血压下降。并能明显减少肾素分泌,作用强于甲基多巴。服药后30分钟有效,可维持6~8小时。常见商品名为血压得平、氯压定、可乐宁、可乐定,适用于治疗中度及重度高血压,亦可治偏头痛、绝经期潮热、痛经、戒绝阿片瘾毒症状。 美国食品药物管理局(FDA)已经批准盐酸可乐定缓释片(规格0.1mg和0.2mg)单用或联合兴奋剂用于治疗6岁至17岁的注意力缺陷多动症(ADHD)患儿。
  • 类别:有毒物质
  • 可燃性危险特性:明火、受热、氧化剂可燃; 燃烧排放有毒氯化物和氮氧化物烟雾
  • 方法一:由2,6-二氯苯胺经甲酰化、氯化、环合而得。将所得可乐定与无水乙醇及活性炭一起搅拌,加热回流,滤除活性炭,滤液加入氯化氢乙醇溶液中成盐,冷却结晶,过滤,用无水乙醇洗结晶,干燥,得可乐定盐酸盐。
  • 灭火剂:雾状水、泡沫、砂土、二氧化碳、1211灭火剂
  • 急性毒性:口服- 大鼠 LD50 67.3 毫克/ 公斤; 口服- 小鼠 LD50: 108 毫克/公斤
  • 不良反应:常见:最常见口干(与剂量有关),昏睡,头晕,精神抑郁,便秘和镇静,性功能降低和夜尿多,瘙痒,恶心、呕吐,失眠,荨麻疹、血管神经性水肿和风疹,疲劳,直立性症状,紧张和焦躁,脱发,皮疹,厌食和全身不适,体重增加,头痛,乏力,戒断综合征,短暂肝功能异常。 少见:肌肉关节痛,心悸、心动过速、心动过缓,下肢痉挛,排尿困难,男性乳房发育,尿潴留,更少见有多梦、夜游症、烦躁不安、兴奋、幻视幻听、谵妄、雷诺现象、心力衰竭,心电图异常如传导紊乱、心律失常、乙醇过敏、发烧、短暂血糖升高、血清肌酸磷酸激酶升高、肝炎和腮腺炎等。
  • 毒性分级:高毒
  • 刺激数据:皮肤-兔 500 毫克 轻度
  • 上游原料:2,6-二氯苯胺 --> 氯化氢乙醇溶液 --> 可乐定盐酸盐
  • 用法用量:1.降低血压口服,起始剂量0.1 mg,一日2次;需要时隔2~4天递增,每日0.1~0.2mg。常用维持剂量为0.3~0.9mg/日,分2~4次口服。严重高血压需紧急治疗时开始口服0.2mg,继以每小时0.1mg,直到舒张压控制或总量达 0.7mg,然后用维持剂量。 2.绝经期潮热一次0.025~0.075mg,每日2次。 3.严重痛经口服 0.025mg,每日2次,在月经前及月经时,共服14日。 4.偏头痛一次 0.025mg,每日2~4次,最多为 0.05mg,每日3次。 5.极量一次0.6mg,一日2.4mg。
  • MOL 文件:4205-90-7.mol
  • 用途一:中枢性降压药,用于治疗中度高血压症。
  • 注意事项:与噻嗪类利尿剂合用,可增加降压效果,消除水钠潴留,并可减少耐药性及用药剂量。 突然停药可致暂时性交感神经活动亢进。 与三环类抗抑郁药、非类固醇消炎药及β受体阻滞剂并用,盐酸可乐定作用减弱。
  • 储运特性:库房通风低温干燥; 轻装轻卸、与氧化剂和酸类分开存放

系列性分类


相关产品推荐